TIMP1 and liver dysplastic nodule: If these molecular mechanisms are determined, the roles of the two epigenetic regulatory mechanisms, whereby decreased Sirt1 regulates Claudin-1 in podocytes and mitigated Nampt increases TIMP-1 levels on new therapeutic targets in DN, may become more significant in the future.